To learn how participants of past research studies are doing 1-5 years after completing the T-STEP program

A multiple case study to determine the impact of Peaceful Schools' Restorative Justice initiatives on relationship building in K-12 schools.

Outcome measures are ways we tell how well babies are doing in the hospital or after going home. Outcome measures used in research may not be the best. One reason is that medications, devices, or care practices can affect many different organ systems, so it is important evaluate more than one area. Another is deciding whether to measure outcomes while the infant is still in the hospital or to wait see how the infant is doing after going home. That decision is complex; one consideration is that some families cannot be reached after going home and their valuable information is lost. Finally, researchers and doctors often view outcomes differently than families. While it is important researchers and doctors make sure outcomes are valid and medically relevant, it is just as important to understand parents' and caregivers' opinions on outcome measures.

The mission of the Collaborative Islet Transplant Registry (CITR) is to expedite progress and promote safety in islet/beta cell transplantation through the collection, analysis, and communication of comprehensive and current data on all islet/beta cell transplants performed in North America, Europe and Australia.

The primary purpose of this research study is to learn about how the level of a protein called p16 changes in the blood of children, adolescents, and adults with sickle cell disease. This protein can provide information about cellular aging which has not been studied before in patients with sickle cell disease. This can help develop future areas of research into sickle cell disease.

The purpose of this study is to test the urine of infants who have a positive new born screening for Cystic Fibrosis (CF) for the presence of specific chemicals.

To determine whether newly-developed naloxone training materials increase how often pharmacists dispense naloxone.

I will conduct focus groups with Venezuelan migrants in Colombia to see the effects of gender on migrants' access to state services like public schools and the police.

This is a multicenter, open-label study to study the safety and characteristics of DNL310, an investigational drug designed to treat both the body and brain manifestations of Mucopolysaccharidosis type II (MPS II; Hunter syndrome). The plan is for each participant to start at a low dose and increase over time until a final dose is achieved. Blood, urine and CSF samples will be taken, and tests and assessments will be done to see how your child is doing in the study.

To assess how the Medical Staff of UNC view interventions to prevent COVID acquisition